Evidence map›Paper›PMID 38536981›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia2024

Relative incidence of interstitial lung diseases in Brazil.

Simone Lobo Krupok Matias, Carlos Alberto de Castro Pereira, Maria Raquel Soares, Flávia Castro Velasco Fernandes, Maria Auxiliadora Carmo Moreira, Fernanda Maciel de Aguiar Baptista, Tarciane Aline Prata, Gediel Cordeiro Junior, Eliane Viana Mancuzo

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Global epidemiology and burden of interstitial lung disease.The Lancet. Respiratory medicine · 2025
    Review
  5. Examining the incidence of interstitial lung disease subtypes in South America.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Simone Lobo Krupok MatiasHospital São Paulo, Universidade Federal de São Paulo, São Paulo (SP) Brasil.ORCID 0000-0002-0953-5605
Carlos Alberto de Castro PereiraHospital São Paulo, Universidade Federal de São Paulo, São Paulo (SP) Brasil.ORCID 0000-0002-0352-9589
Maria Raquel SoaresHospital São Paulo, Universidade Federal de São Paulo, São Paulo (SP) Brasil.ORCID 0000-0002-2242-2533
Flávia Castro Velasco FernandesHospital das Clínicas, Universidade Federal de Goiás, Goiânia (GO) Brasil.ORCID 0000-0002-5973-2877
Maria Auxiliadora Carmo MoreiraHospital das Clínicas, Universidade Federal de Goiás, Goiânia (GO) Brasil.ORCID 0000-0002-6639-0633
Fernanda Maciel de Aguiar BaptistaHospital São Rafael, Instituto D'Or de Ensino e Pesquisa em Salvador, Salvador (BA) Brasil.ORCID 0009-0008-4733-4282
Tarciane Aline PrataFundação Hospitalar do Estado de Minas Gerais, Hospital Júlia Kubistchek, Belo Horizonte (MG) Brasil.ORCID 0000-0002-4765-2685
Gediel Cordeiro JuniorFundação Hospitalar do Estado de Minas Gerais, Hospital Júlia Kubistchek, Belo Horizonte (MG) Brasil.ORCID 0000-0002-2657-5481
Eliane Viana MancuzoHospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte (MG) Brasil.ORCID 0000-0003-3891-875X
3C Institute · USFundação Hospitalar do Estado de Minas Gerais · BRHospital das Clínicas da Universidade Federal de Minas Gerais · BRHospital São Rafael · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the relative frequency of incident cases of interstitial lung diseases (ILDs) in Brazil.

methodsThis was a retrospective survey of new cases of ILD in six referral centers between January of 2013 and January of 2020. The diagnosis of ILD followed the criteria suggested by international bodies or was made through multidisciplinary discussion (MDD). The condition was characterized as unclassifiable ILD when there was no specific final diagnosis following MDD or when there was disagreement between clinical, radiological, or histological data.

resultsThe sample comprised 1,406 patients (mean age = 61 ± 14 years), and 764 (54%) were female. Of the 747 cases exposed to hypersensitivity pneumonitis (HP)-related antigens, 327 (44%) had a final diagnosis of HP. A family history of ILD was reported in 8% of cases. HRCT findings were indicative of fibrosis in 74% of cases, including honeycombing, in 21%. Relevant autoantibodies were detected in 33% of cases. Transbronchial biopsy was performed in 23% of patients, and surgical lung biopsy, in 17%. The final diagnoses were: connective tissue disease-associated ILD (in 27%), HP (in 23%), idiopathic pulmonary fibrosis (in 14%), unclassifiable ILD (in 10%), and sarcoidosis (in 6%). Diagnoses varied significantly among centers (c2 = 312.4; p < 0.001).

conclusionsOur findings show that connective tissue disease-associated ILD is the most common ILD in Brazil, followed by HP. These results highlight the need for close collaboration between pulmonologists and rheumatologists, the importance of detailed questioning of patients in regard with potential exposure to antigens, and the need for public health campaigns to stress the importance of avoiding such exposure.

Indexed as

Alveolitis, Extrinsic AllergicConnective Tissue DiseasesIdiopathic Pulmonary FibrosisLung Diseases, InterstitialAgedBrazilFemaleHumansIncidenceMaleMiddle AgedRetrospective Studies

Identifiers

PMID38536981
PMCPMC11095929
OpenAlexW4392284508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.